ESCRS Today looks at 25 Years of Progress in CXL
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
Mark Hillen
September 14, 2024
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
The AAO-ESCRS Joint Symposium, convened leading ophthalmology experts to explore the latest developments in CXL.
Monday, September 9 is the last day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Sunday, September 8th is the third day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Saturday, September 7 is the second day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Friday, September 6 was the first day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons. Here’s a collection of images from that day.
ELZA-PACE not only improves corneal biomechanics (just like regular CXL) but by flattening the cone significantly, also enhances patients’ visual quality. The results so far indicate that patients treated with this method have better visual outcomes compared to traditional CXL treatments.
Here’s an overview of what ELZA’s surgeons and researchers are presenting in Barcelona this year. ELZA at ESCRS 2024.
On August 12, 2023, at Humo Arena, Tashkent, 63 Down syndrome children were screened for keratoconus under Nikki Hafezi’s leadership. Discover the importance of early detection.
Ophthalmologie Nachrichten recently featured an article from the ELZA Institute, highlighting advancements in corneal cross-linking (CXL). This new approach allows the procedure to be conducted at the slit lamp, significantly reducing costs and extending access to advanced eye care in underserved regions. The innovative method is especially effective for treating keratoconus and infectious keratitis. By optimizing UV exposure times, ELZA’s researchers have made CXL more efficient and accessible, democratizing high-quality ophthalmic treatments globally.
